The Impact of the Gut Microbiome on Cancer Immunotherapy Efficacy

The complex interplay between bacteria and the tumor microenvironment informs cancer immunotherapy strategies.

Scientists once thought that tumors existed in pristine microenvironments devoid of microorganisms. But over the last 20 years, scientists have found bacteria inside tumors that contribute to tumor growth and influence patients’ responses to immunotherapies. In this webinar brought to you by Illumina, Fyza Shaikh will discuss how RNA sequencing reveals insights into the gut microbiome’s role in tumorigenesis and a patient’s response to cancer therapeutics. 

Topics to be covered

  • Understanding the gut microbiome’s role in patient response to immunotherapy
  • Using 16S rRNA amplicon sequencing to identify gut microbes that impact cancer immunotherapy 

Thursday, June 22nd, 2023 | 2:30 PM - 3:30 PM Eastern Time
This webinar will be available to view live and on demand.

Fyza Shaikh MD, PhD


Fyza Shaikh MD, PhD

Assistant Professor
Johns Hopkins School of Medicine

Sponsored by